VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients

被引：22

作者：

Horie, Takahiro ^{[1
]}

Ono, Koh ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, 54 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan

来源：

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2024年 / 10卷 / 02期

关键词：

D O I：

10.1093/ehjcvp/pvad103

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：89 / 90

页数：2

共 5 条

[1] Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors [J].

Anzalone, Andrew V. ;

Koblan, Luke W. ;

Liu, David R. .

NATURE BIOTECHNOLOGY, 2020, 38 (07) :824-844

[2] Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage [J].

Gaudelli, Nicole M. ;

Komor, Alexis C. ;

Rees, Holly A. ;

Packer, Michael S. ;

Badran, Ahmed H. ;

Bryson, David I. ;

Liu, David R. .

NATURE, 2017, 551 (7681) :464-+

[3] Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models [J].

Lee, Richard G. ;

Mazzola, Anne Marie ;

Braun, Maurine C. ;

Platt, Colin ;

Vafai, Scott B. ;

Kathiresan, Sekar ;

Rohde, Ellen ;

Bellinger, Andrew M. ;

Khera, Amit, V .

CIRCULATION, 2023, 147 (03) :242-253

[4] Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol [J].

Ray, Kausik K. ;

Wright, R. Scott ;

Kallend, David ;

Koenig, Wolfgang ;

Leiter, Lawrence A. ;

Raal, Frederick J. ;

Bisch, Jenna A. ;

Richardson, Tara ;

Jaros, Mark ;

Wijngaard, Peter L. J. ;

Kastelein, John J. P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (16) :1507-1519

[5]

Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]

← 1 →